Company Filing History:
Years Active: 2012
Title: Shunying Zhu: Innovator in Myeloprotective Therapies
Introduction
Shunying Zhu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical science, particularly in the area of myeloprotective agents. His innovative work focuses on enhancing bone marrow regeneration and improving the health of patients undergoing chemotherapy.
Latest Patents
Shunying Zhu holds a patent titled "Methods of using interleukin-1 receptor antagonist as a myeloprotective agent." This invention relates to the use of interleukin-1 receptor antagonist (IL-1Ra) to promote bone marrow regeneration, increase peripheral white blood cells, and elevate platelet levels in subjects when administered prior to chemotherapy. The patent highlights the potential of IL-1Ra as an adjuvant therapy to mitigate the hematopoietic toxicities associated with chemotherapy.
Career Highlights
Zhu is associated with General Regeneratives, Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve patient outcomes in cancer treatment.
Collaborations
Shunying Zhu collaborates with notable colleagues, including Wei Han and Jing Jing Zhang. Their combined expertise contributes to the innovative research being conducted at General Regeneratives, Ltd.
Conclusion
Shunying Zhu's contributions to the field of myeloprotective therapies exemplify the impact of innovative research on patient care. His work in utilizing interleukin-1 receptor antagonists represents a significant advancement in the treatment of chemotherapy-related complications.